LMTK2 inhibits Ab25-35-elicited ferroptosis, oxidative stress and apoptotic damage in PC12 cells through activating Nrf2/ARE signalling pathway
Folia Neuropathologica · 2024
DOI: 10.5114/fn.2023.133472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Neuropathologica, 2024. Verfasst von Lili Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Zutangshan Hospital, Nanjing, China. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Apoptosis, Ferroptosis, NF-E2-Related Factor 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Alzheimer's disease (AD), the most common contributor to dementia, is a growing global health problem. This study aimed to investigate the role of lemur tyrosine kinase 2 (LMTK2) in AD as well as its relevant mechanism. To establish an in vitro cell model, PC12 cells were challenged with 20 µmol/l Ab 25-35 for 24 h. RT-qPCR and western blot examined LMTK2 mRNA and protein expressions. With the application of CCK-8, TUNEL, iron colorimetric assay kit and DCFH-DA, the viability, apoptosis, Fe 2+ and ROS content in PC12 cells were assessed. Besides, the expressions of oxidative stress-, apoptosis-, ferroptosis- and Nrf2/ARE signalling-related proteins were evaluated with western blot. Moreover, commercial kits examined SOD, MDA and CAT contents. The results manifested that LMTK2 expression was noticeably downregulated in Ab 25-35 -treated PC12 cells. Notably, LMTK2 overexpression exhibited inhibitory effects on oxidative stress, apoptosis and ferroptosis in PC12 cells exposed to Ab 25-35 . The upregulated Nrf2, NQO1 and HO-1 expressions in LMTK2 overexpressed-PC12 cells with Ab 25-35 induction revealed that LMTK2 overexpression could activate the Nrf2/ARE signalling pathway. What is more, a series of cellular experiments further testified that ML385, a specific Nrf2 inhibitor, partly hindered the protective role of LMTK2 overexpression against Ab 25-35 -triggered oxidative stress, apoptosis and ferroptosis in PC12 cells. In conclusion, LMTK2 overexpression alleviated the ferroptosis, oxidant damage and apoptosis in PC12 cells exposed to Ab 25-35 through the activation of the Nrf2/ARE signalling pathway, indicating the potential target of LMTK2 in the treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Zutangshan Hospital, Nanjing, China.
- Department of Psychiatry, Nanjing Brain Hospital, Nanjing, China.
Zitieren
APA
Zhang, L., & Shu, F. (2024). LMTK2 inhibits Ab25-35-elicited ferroptosis, oxidative stress and apoptotic damage in PC12 cells through activating Nrf2/ARE signalling pathway. Folia Neuropathologica. https://doi.org/10.5114/fn.2023.133472
Vancouver
Zhang L, Shu F. LMTK2 inhibits Ab25-35-elicited ferroptosis, oxidative stress and apoptotic damage in PC12 cells through activating Nrf2/ARE signalling pathway. Folia Neuropathologica. 2024. doi:10.5114/fn.2023.133472
BibTeX
@article{Zhang2024,
author = {Zhang, Lili and Shu, Fei},
title = {LMTK2 inhibits Ab25-35-elicited ferroptosis, oxidative stress and apoptotic damage in PC12 cells through activating Nrf2/ARE signalling pathway},
journal = {Folia Neuropathologica},
year = {2024},
doi = {10.5114/fn.2023.133472}
}
EUVIMED